News & Updates

A network meta-analysis (NMA) reports that the combination regimen comprising atezolizumab and bevacizumab appears to be better than other first-line systemic therapeutic alternatives for advanced hepatocellular carcinoma (HCC) in terms of providing a balance between overall survival (OS) benefit and quality of life (QoL) preservation.

As cliché as it sounds, adopting a healthy lifestyle helps prevent the development of colorectal cancer (CRC). A recent study has shown that adhering to well-balanced diet, maintaining a normal weight, staying physically active, and avoiding tobacco and alcohol all contribute to a reduction in CRC risk.